Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-004781
Abstract: Background Single-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond. This is likely due to diverse immunosuppressive mechanisms acting in a concerted way to suppress… read more here.
Keywords: immunogenic tumors; combination immunotherapy; immunotherapy; antigen agnostic ... See more keywords